|
C16ORF87 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.661700E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.178600E-04 |
| Normal-vs-Stage2 |
5.424500E-02 |
| Normal-vs-Stage3 |
9.940800E-01 |
| Normal-vs-Stage4 |
8.343600E-01 |
| Stage1-vs-Stage2 |
4.839600E-01 |
| Stage1-vs-Stage3 |
4.924300E-03 |
| Stage1-vs-Stage4 |
1.217980E-01 |
| Stage2-vs-Stage3 |
1.243610E-01 |
| Stage2-vs-Stage4 |
3.706600E-01 |
| Stage3-vs-Stage4 |
8.269200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.977900E-03 |
| Normal-vs-AfricanAmerican |
1.677610E-02 |
| Normal-vs-Asian |
7.167200E-01 |
| Caucasian-vs-AfricanAmerican |
8.227600E-01 |
| Caucasian-vs-Asian |
3.304600E-01 |
| AfricanAmerican-vs-Asian |
3.520600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.084880E-03 |
| Normal-vs-Female |
7.111500E-02 |
| Male-vs-Female |
5.843900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.143600E-03 |
| Normal-vs-Extreme_Weight |
4.33760000000394E-05 |
| Normal-vs-Obese |
1.267890E-02 |
| Normal-vs-Extreme_Obese |
2.782600E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.204600E-01 |
| Normal_Weight-vs-Obese |
2.108400E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.941600E-01 |
| Extreme_Weight-vs-Obese |
5.996400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
1.464000E-01 |
| Obese-vs-Extreme_Obese |
6.343000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.499400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.375500E-03 |
| Normal-vs-Age(61-80Yrs) |
4.832200E-04 |
| Normal-vs-Age(81-100Yrs) |
1.502620E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.132400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.444990E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.398600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.397400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.362200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.764200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.20099999995271E-06 |
| Normal-VS-Type2 PRCC |
5.779000E-01 |
| Normal-VS-KIRP CIMP |
4.738000E-01 |
| Normal-VS-Unclassified PRCC |
1.821510E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.021750E-03 |
| Type1 PRCC-VS-KIRP CIMP |
4.424500E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
5.058000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.553800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.912210E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.996000E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.594200E-02 |
| Normal-vs-N1 |
4.521200E-01 |
| Normal-vs-N2 |
1.376370E-01 |
| N0-vs-N1 |
5.130300E-02 |
| N0-vs-N2 |
7.534400E-01 |
| N1-vs-N2 |
2.245200E-01 |
|
|
